REALITY-AHF

Title: 本邦における急性心不全急性期治療と予後との関係性に関する多施設レジストリー研究（Registry focused on very early presentation and treatment in emergency department of acute heart failure syndrome: REALITY-AHF）

Study design: 前向き多施設観察研究

Objectives: 急性心不全の救急部における超急性期治療を含む、急性期治療の実態と予後との関連を検討する事

Study registration: UMIN-CTR (UMIN000014105) (English)

Publications:

  1. Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
    Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T.
    J Am Coll Cardiol. 2017 Jun 27;69(25):3042-3051. doi: 10.1016/j.jacc.2017.04.042.
  2. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T, Kitai T, Miyamoto T, Kagiyama N, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Yamaguchi J, Iwai T, Hijikata S, Masuda R, Miyazaki R, Hara N, Nagata Y, Nozato T, Matsue Y.
    Am J Cardiol. 2018 Apr 15;121(8):969-974. doi: 10.1016/j.amjcard.2018.01.006.

  3. Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure.
    Kitai T, Tang WHW, Xanthopoulos A, Murai R, Yamane T, Kim K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Kaji S, Furukawa Y, Matsue Y.
    Open Heart. 2018 Jul 11;5(2):e000845. doi: 10.1136/openhrt-2018-000845.
  4. The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF.
    Kagiyama N, Matsue Y.
    Anatol J Cardiol. 2018 Aug;20(2):125-129. doi: 10.14744/AnatolJCardiol.2018.88935.

  5. Very Early Diuretic Response After Admission for Acute Heart Failure.
    Kuroda S, Damman K, Ter Maaten JM, Voors AA, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kitai T, Yoshida K, Matsumura A, Matsue Y.
    J Card Fail. 2019 Jan;25(1):12-19. doi: 10.1016/j.cardfail.2018.09.004.
  6. 9-Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries.
    Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, Matsue Y.
    J Am Heart Assoc. 2018 Sep 18;7(18):e008687. doi: 10.1161/JAHA.118.008687.
  7. Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure　- Insights From REALITY-AHF.
    Kondo T, Okumura T, Matsue Y, Shiraishi A, Kagiyama N, Yamaguchi T, Kuroda S, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T, Murohara T.
    Circ J. 2018 Dec 25;83(1):174-181. doi: 10.1253/circj.CJ-18-0724.

  8. Prognostic Value of BNP Reduction during Hospitalization in Patients with Acute Heart Failure.
    Kagiyama N, Kitai T, Hayashida A, Yamaguchi T, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Suzuki S, Yamamoto M, Shimizu A, Urakami Y, Toki M, Aritaka S, Matsumoto K, Nagano N, Yamamoto K, Matsue Y.
    J Card Fail. 2019 Apr 6. pii: S1071-9164(18)31340-X. doi: 10.1016/j.cardfail.2019.04.004.

  9. Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure.
    Yoshioka K, Matsue Y, Yamaguchi T, Kitai T, Kagiyama N, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kuroda S, Matsumura A, Hirao K.
    Am J Cardiovasc Drugs. 2019 Jun 20. doi: 10.1007/s40256-019-00355-3.

  10. Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure.
    Kitai T, Xanthopoulos A, Tang WHW, Kaji S, Furukawa Y, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Skoularigis J, Triposkiadis F, Matsue Y.
    Int J Cardiol. 2019 Dec 28. pii: S0167-5273(19)35400-2. doi: 10.1016/j.ijcard.2019.12.051.

  11. The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions.
    Motiejūnaitė J, Akiyama E, Cohen-Solal A, Maggioni AP, Mueller C, Choi DJ, Kavoliūnienė A, Čelutkienė J, Parenica J, Lassus J, Kajimoto K, Sato N, Miró Ò, Peacock WF, Matsue Y, Voors AA, Lam CSP, Ezekowitz JA, Ahmed A, Fonarow GC, Gayat E, Regitz-Zagrosek V, Mebazaa A.
    Eur Heart J. 2020 Mar 3. pii: ehaa071. doi: 10.1093/eurheartj/ehaa071.

  12. Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure.
    Hayasaka K, Matsue Y, Kitai T, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Yoshioka K, Kuroda S, Kagiyama N, Yamaguchi T, Sasano T.
    Eur Heart J Cardiovasc Imaging. 2020 Mar 11. pii: jeaa035. doi: 10.1093/ehjci/jeaa035.

  13. Clinical and Prognostic Values of ALBI Score in Patients With Acute Heart Failure.
    Matsue Y, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamot M, Mizutani K, Yoshida K, Kitai T.
    Heart Lung Circ. 2019 Dec 23. pii: S1443-9506(19)31553-7. doi: 10.1016/j.hlc.2019.12.003.